Suppr超能文献

拉贝洛尔累积剂量在围手术期高血压治疗中的安全性。

The safety of cumulative doses of labetalol in perioperative hypertension.

作者信息

Cosentino F, Vidt D G, Orlowski J P, Shiesley D, Little J R

出版信息

Cleve Clin J Med. 1989 Jun;56(4):371-6. doi: 10.3949/ccjm.56.4.371.

Abstract

Intravenous labetalol is commonly used in the management of hypertensive emergencies or urgencies as well as postoperative hypertension. The maximum recommended dose in any clinical setting is 300 mg in 24 hours. The safety of administering high doses of intravenous labetalol (greater than 300 mg in 24 hours) was evaluated in neurosurgical patients (n = 9). During 15 distinct periods of 24 hours or less, the mean dose of labetalol given was 623 +/- 86 mg. Adverse hemodynamic and biochemical effects were minor and easily reversible. Intravenous labetalol can safely be used in doses exceeding 300 mg per 24 hours in neurosurgical patients.

摘要

静脉注射拉贝洛尔常用于治疗高血压急症或亚急症以及术后高血压。在任何临床情况下,推荐的最大剂量为24小时内300毫克。对神经外科患者(n = 9)评估了静脉注射高剂量拉贝洛尔(24小时内超过300毫克)的安全性。在15个24小时或更短的不同时间段内,拉贝洛尔的平均给药剂量为623±86毫克。不良血流动力学和生化影响较小且易于逆转。在神经外科患者中,静脉注射拉贝洛尔可以安全地使用超过每24小时300毫克的剂量。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验